Insulin resistance in non-obese women with polycystic ovary syndrome: Relation to byproducts of oxidative stress

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 7, 2011, Pages 451-455

  MacUt, D ^a   Simic, T ^a   Lissounov, A ^a   Pljesa Ercegovac, M ^a   Bozic, I ^a   Djukic, T ^a   Bjekic Macut, J ^b   Matic, M ^a   Petakov, M ^a   Suvakov, S ^a   Damjanovic, S ^a   Savic Radojevic, A ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CHC Bezanijska Kosa ^*  (Serbia)

Author keywords

lipid peroxidation; nitrotyrosine; oxidative stress; polycystic ovary syndrome

Indexed keywords

3 NITROTYROSINE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; URIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; ANTIOXIDANTS; BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; MALONDIALDEHYDE; OXIDATIVE STRESS; OXIDOREDUCTASES; POLYCYSTIC OVARY SYNDROME; TYROSINE; URIC ACID;

EID: 79960191581     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0031-1279740     Document Type: Article

References (32)

1. Azziz R, Woods KS, Reyna R et al,. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004 89 2745-2749 (Pubitemid 38766360)
2. Balen AH, Laven JS, Tan SL et al,. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003 9 505-514 (Pubitemid 38072143)
3. Bausenwein J, Serke H, Eberle K et al,. Elevated levels of oxidized low-density lipoprotein and of catalase activity in follicular fluid of obese women. Mol Hum Reprod 2010 16 117-124
4. Carmina E, Orio F, Palomba S et al,. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 2005 152 389-394 (Pubitemid 40439491)
5. Cussons AJ, Stuckey BG, Watts GF. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis 2006 185 227-239
6. De Simone G, Devereux RB, Roman MJ et al,. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 1994 23 600-606 (Pubitemid 24129354)
7. Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med 1995 98 33S-39S
8. Ferrannini E, Natali A, Bell P et al,. Insulin resistance and hypersecretion in obesity. European group for the study of insulin resistance (EGIR). J Clin Invest 1997 100 1166-1173
9. Gonzalez F, Rote NS, Minium J et al,. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 2006 91 336-340 (Pubitemid 43069159)
10. Goodarzi MO, Korenman SG. The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril 2003 80 255-258 (Pubitemid 36959775)
11. Hatch R, Rosenfield RL, Kim MH et al,. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981 140 815-830 (Pubitemid 11046650)
12. Karadeniz M, Erdogan M, Tamsel S et al,. Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances. Exp Clin Endocrinol Diabetes 2008 116 231-235 (Pubitemid 351600585)
13. Kaya MG, Gunebakmaz O, Zencir C et al,. An assessment of the elastic properties of the aorta in nonobese women with polycystic ovary syndrome. Fertil Steril 2010 94 2402-2405
14. Kim JA, Montagnani M, Koh KK et al,. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006 113 1888-1904 (Pubitemid 43739401)
15. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J Clin Invest 1992 89 1006-1013
16. Kuscu NK, Var A. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstet Gynecol Scand 2009 88 612-617
17. Laven JS, Imani B, Eijkemans MJ et al,. New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 2002 57 755-767 (Pubitemid 35379455)
18. Lee YS, Kim AY, Choi JW et al,. Dysregulation of adipose glutathione peroxidase 3 in obesity contributes to local and systemic oxidative stress. Mol Endocrinol 2008 22 2176-2189
19. Macut D, Damjanovic S, Panidis D et al,. Oxidised low-density lipoprotein concentration early marker of an altered lipid metabolism in young women with PCOS. Eur J Endocrinol 2006 155 131-136 (Pubitemid 44103381)
20. Mathur RS, Moody LO, Landgrebe S et al,. Plasma androgens and sex hormone-binding globulin in the evaluation of hirsute females. Fertil Steril 1981 35 29-35 (Pubitemid 11168911)
21. Matthews DR, Hosker JP, Rudenski AS et al,. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419 (Pubitemid 15018832)
22. Orio F Jr, Palomba S, Cascella T et al,. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004 89 4588-4593 (Pubitemid 39244474)
23. Orio F, Vuolo L, Palomba S et al,. Metabolic and cardiovascular consequences of polycystic ovary syndrome. Minerva Ginecol 2008 60 39-51 (Pubitemid 351517721)
24. Paradisi G, Steinberg HO, Hempfling A et al,. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001 103 1410-1415 (Pubitemid 32220633)
25. Rifici VA, Schneider SH, Khachadurian AK. Stimulation of low-density lipoprotein oxidation by insulin and insulin like growth factor I. Atherosclerosis 1994 107 99-108 (Pubitemid 24159057)
26. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004 81 19-25
27. Sabuncu T, Vural H, Harma M et al,. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem 2001 34 407-413 (Pubitemid 32777851)
28. Sahin Y, Unluhizarci K, Yilmazsoy A et al,. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2007 67 904-908 (Pubitemid 350135135)
29. Shin MJ, Lee JH, Jang Y et al,. Insulin resistance, adipokines, and oxidative stress in nondiabetic, hypercholesterolemic patients: leptin as an 8-epi-prostaglandin F2alpha determinant. Metabolism 2006 55 918-922 (Pubitemid 44183818)
30. Simic DV, Mimic-Oka J, Pljesa-Ercegovac M et al,. Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. J Hum Hypertens 2006 20 149-155 (Pubitemid 43148617)
31. Song P, Wu Y, Xu J et al,. Reactive nitrogen species induced by hyperglycemia suppresses Akt signaling and triggers apoptosis by upregulating phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) in an LKB1-dependent manner. Circulation 2007 116 1585-1595 (Pubitemid 47511422)
32. Yilmaz M, Bukan N, Ayvaz G et al,. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Hum Reprod 2005 20 3333-3340 (Pubitemid 41742509)